CXCR2 Inhibition – a novel approach to treating CoronAry heart DiseAse (CICADA): study protocol for a randomised controlled trial

Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial

(2016) Paul M O'Byrne et al.   Lancet Respiratory Medicine

The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions

(2015) Stipo Jurcevic et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis

(2015) Anthony De Soyza et al.   EUROPEAN RESPIRATORY JOURNAL

The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD

(2015) A.M. Kirsten et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Usefulness of the Neutrophil-to-Lymphocyte Ratio to Predict Bare-Metal Stent Restenosis

(2012) Osman Turak et al.   AMERICAN JOURNAL OF CARDIOLOGY

Neutrophil-active chemokines in in vivo imaging of neutrophil trafficking

(2012) Maria-Jesus Sanz et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Quantification of Absolute Myocardial Perfusion in Patients With Coronary Artery Disease

(2012) Geraint Morton et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease

(2012) Stefan M. Nidorf et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Improved Cardiac Risk Assessment With Noninvasive Measures of Coronary Flow Reserve

(2011) Venkatesh L. Murthy et al.   CIRCULATION

Neutrophils cascading their way to inflammation

(2011) Christian D. Sadik et al.   TRENDS IN IMMUNOLOGY

High Neutrophil Numbers in Human Carotid Atherosclerotic Plaques Are Associated With Characteristics of Rupture-Prone Lesions

(2010) Mihaela G. Ionita et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis

(2010) Maik Drechsler et al.   CIRCULATION

Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques

(2009) Fabio R Tavora et al.   BMC Cardiovascular Disorders

CD40 Ligand Promotes Mac-1 Expression, Leukocyte Recruitment, and Neointima Formation after Vascular Injury

(2008) Guohong Li et al.   AMERICAN JOURNAL OF PATHOLOGY